Epidermal Growth Factor Receptor Mutants from Human Lung Cancers Exhibit Enhanced Catalytic Activity and Increased Sensitivity to Gefitinib
Roseann Mulloy(Harvard University), Jeffrey Settleman(Enzo Life Sciences (United States))
Cited by 191
Related Papers
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
|Genes & Development|2007|445
Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
|Cancer Research|2008|403
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
|Proceedings of the National Academy of Sciences|2007|358